BioMed Research International / 2020 / Article / Tab 1

Clinical Study

Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19

Table 1

General characteristics of patients with COVID-19.

VariablesNumber of patientsProportion (%)

Sex
 Male1545.0
 Female1855.0
Age
 0-6 years00
 7-17 years412.1
 18-40 years618.2
 41-65 years1854.6
 ≥66 years515.6
Comorbidity
 Hypertension515.2
 Diabetes26.1
Clinical classification
 Mild39.1
 Ordinary3090.9
Residence
 Hubei1855.0
 Yunnan1545.0
Lymphocyte absolute value after admission (normal: /L)
 Normal2884.9
 Reduced515.2
CD3+ T cell after admission (normal: 1027-2086/μL)
 Normal2060.6
 Reduced1339.4
CD4+ T cell after admission (normal: 706-1125/μL)
 Increased26.1
 Normal515.2
 Reduced2678.8
CD8+ T cell after admission (normal: 323-836/μL)
 Normal1648.5
 Reduced1751.52
Treated with glucocorticoids
 Yes1339.4
 No2060.6

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.